Patents by Inventor Kim Lickteig

Kim Lickteig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Marks as modifers of the PTEN pathway and methods of use
    Patent number: 8273536
    Abstract: Human MARK genes are identified as modulators of the PTEN pathway, and thus are therapeutic targets for disorders associated with defective PTEN function. Methods for identifying modulators of PTEN, comprising screening for agents that modulate the activity of MARK are provided.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: September 25, 2012
    Assignee: Exelixis, Inc.
    Inventors: Michael R. Costa, Garth Joseph McGrath, Kim Lickteig, Timothy S. Heuer
  • PSMCs As Modifiers of the RB Pathway and Methods of Use
    Publication number: 20120107827
    Abstract: Human PSMC genes are identified as modulators of the RB pathway, and thus are therapeutic targets for disorders associated with defective RB function. Methods for identifying modulators of RB, comprising screening for agents that modulate the activity of PSMC are provided.
    Type: Application
    Filed: October 12, 2011
    Publication date: May 3, 2012
    Applicant: EXELIXIS, INC.
    Inventors: ALBERT K. TAI, CHUNYAN SONG, MICHAEL MARTIN OLLMANN, LUCILE A. GILLETT, JOANNE I. ADAMKEWICZ, KIM LICKTEIG
  • MAPKs as modifiers of the rac, axin, and beta-catenin pathways and methods of use
    Patent number: 8067180
    Abstract: Human MAPK genes are identified as modulators of the Rac, axin, and beta-catenin pathways, and thus are therapeutic targets for disorders associated with defective Rac, axin, and beta-catenin function. Methods for identifying modulators of Rac, axin, and beta-catenin, comprising screening for agents that modulate the activity of MAPK are provided.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: November 29, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lisa C. Kadyk, George Ross Francis, Steven Brian Gendreau, Emery G. Dora, III, Michael R. Costa, Kim Lickteig
  • MELKS as modifiers of the Rac pathway and methods of use
    Patent number: 8067181
    Abstract: Human MELK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MELK are provided.
    Type: Grant
    Filed: August 12, 2004
    Date of Patent: November 29, 2011
    Assignee: Exelixis, Inc.
    Inventors: Lisa Kadyk, George Ross Francis, Kim Lickteig, Timothy S. Heuer
  • GFATS As Modifiers of the AXIN Pathway and Methods of Use
    Publication number: 20110167505
    Abstract: Human GFAT genes are identified as modulators of the Axin pathway, and thus are therapeutic targets for disorders associated with defective Axin function. Methods for identifying modulators of Axin, comprising screening for agents that modulate the activity of GFAT are provided.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 7, 2011
    Applicant: EXELIXIS, INC.
    Inventors: Steven Brian Gendreau, Emery G. Dora, III, Kim Lickteig
  • KIFS as Modifiers of the RHO Pathway and Methods of Use
    Publication number: 20110111402
    Abstract: Human KIF23 genes are identified as modulators of the RHO pathway, and thus are therapeutic targets for disorders associated with defective RHO function. Methods for identifying modulators of RHO, comprising screening for agents that modulate the activity of KIF23 are provided.
    Type: Application
    Filed: September 24, 2010
    Publication date: May 12, 2011
    Applicant: EXELIXIS INC.
    Inventors: Joanne ADAMKEWICZ, Craig D. AMUNDSEN, Lynn Margaret BJERKE, George Ross FRANCIS, Timothy S. HEUER, Kim LICKTEIG, Monique NICOLL
  • Psmcs as Modifiers of the Rb Pathway and Methods of Use
    Publication number: 20090013420
    Abstract: Human PSMC genes are identified as modulators of the RB pathway, and thus are therapeutic targets for disorders associated with defective RB function. Methods for identifying modulators of RB, comprising screening for agents that modulate the activity of PSMC are provided.
    Type: Application
    Filed: August 6, 2003
    Publication date: January 8, 2009
    Inventors: Albert K. Tai, Chunyan Song, Michael Martin Ollmann, Lucile A. Gillett, Joanne I. Adamkewicz, Kim Lickteig
  • Kifs as Modifiers of the Rho Pathway and Methods of Use
    Publication number: 20090004180
    Abstract: Human KIF23 genes are identified as modulators of the RHO pathway, and thus are therapeutic targets for disorders associated with defective RHO function. Methods for identifying modulators of RHO, comprising screening for agents that modulate the activity of KIF23 are provided.
    Type: Application
    Filed: November 9, 2006
    Publication date: January 1, 2009
    Applicant: Exelixis Inc.
    Inventors: Joanne Adamkewicz, Craig D. Amundsen, Lynn Margaret Bjerke, George Ross Francis, Timothy S. Heuer, Kim Lickteig, Monique Nicoll
  • Melks as Modifiers of the Rac Pathway and Methods of Use
    Publication number: 20080293044
    Abstract: Human MELK genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MELK are provided.
    Type: Application
    Filed: August 12, 2004
    Publication date: November 27, 2008
    Inventors: Lisa Kadyk, George Ross Francis, Kim Lickteig, Timothy S. Heuer
  • Mapks as Modifiers of the Rac, Axin, and Beta-Catenin Pathways and Methods of Use
    Publication number: 20080229435
    Abstract: Human MAPK genes are identified as modulators of the Rac, axin, and beta-catenin pathways, and thus are therapeutic targets for disorders associated with defective Rac, axin, and beta-catenin function. Methods for identifying modulators of Rac, axin, and beta-catenin, comprising screening for agents that modulate the activity of MAPK are provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: September 18, 2008
    Applicant: EX-ELIXIS, INC
    Inventors: Lisa C. Kadyk, George Ross Francis, Steven Brian Gendreau, Emery G. Dora, Michael R. Costa, Kim Lickteig
  • Mptens as Modifiers of the Pten/Igf Pathway and Methods of Use
    Publication number: 20070274914
    Abstract: Human MPTEN genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of PTEN/IGF, comprising screening for agents that modulate the activity of MPTEN are provided.
    Type: Application
    Filed: May 13, 2004
    Publication date: November 29, 2007
    Inventors: Chunyan Song, Michael Ollmann, Kim Lickteig, HaiGuang Zhang, Lynn Bjerke
  • Ranbp2 as Modifiers of the Pten/Igf Pathway and Methods of Use
    Publication number: 20070269802
    Abstract: Human RANBP2 genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of FEN/IGF, comprising screening for agents that modulate the activity of RANBP2 are provided.
    Type: Application
    Filed: May 13, 2004
    Publication date: November 22, 2007
    Applicant: Exelixis, Inc.
    Inventors: Chunyan Song, Michael Ollmann, Kim Lickteig
  • Flj10607 as modifier of the axin pathway and methods of use
    Publication number: 20070141648
    Abstract: Human FLJ10607 genes are identified as modulators of the Axin pathway, and thus are therapeutic targets for disorders associated with defective Axin function. Methods for identifying modulators of Axin, comprising screening for agents that modulate the activity of FLJ10607 are provided.
    Type: Application
    Filed: December 29, 2003
    Publication date: June 21, 2007
    Inventors: Steven Gendreau, Emery Dora, Kim Lickteig
  • Mracs as modifiers of the rac pathway and methods of use
    Publication number: 20070142271
    Abstract: Human MRAC genes are identified as modulators of the RAC pathway, and thus are therapeutic targets for disorders associated with defective RAC function. Methods for identifying modulators of RAC, comprising screening for agents that modulate the activity of MRAC are provided.
    Type: Application
    Filed: November 24, 2003
    Publication date: June 21, 2007
    Applicant: Exelixis, Inc.
    Inventors: Lisa Kadyk, George Francis, Lynn Bjerke, Kim Lickteig
  • Marks as modifers of the pten pathway and methods of use
    Publication number: 20070059698
    Abstract: Human MARK genes are identified as modulators of the PTEN pathway, and thus are therapeutic targets for disorders associated with defective PTEN function.
    Type: Application
    Filed: June 18, 2004
    Publication date: March 15, 2007
    Applicant: Exelixis, Inc.
    Inventors: Michael Costa, Garth McGrath, Kim Lickteig, Timothy Heuer
  • Mptens as modifers of the pten/igf pathway and methods of use
    Publication number: 20070042371
    Abstract: Human MPTEN genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of PTEN/IGF, comprising screening for agents that modulate the activity of MPTEN are provided.
    Type: Application
    Filed: June 18, 2004
    Publication date: February 22, 2007
    Applicant: Exelixis, Inc
    Inventors: Garth McGrath, Kim Lickteig
  • Tkts as mondifiers of the beta-catenin pathway and methods of use
    Publication number: 20070020628
    Abstract: Human TKT genes are identified as modulators of the beta-catenin pathway, and thus are therapeutic targets for disorders associated with defective beta-catenin function. Methods for identifying modulators of beta-catenin, comprising screening for agents that modulate the activity of TKT are provided.
    Type: Application
    Filed: January 28, 2004
    Publication date: January 25, 2007
    Inventors: Helen Francis-Lang, Christopher Winter, Richard Ventura, Kim Lickteig
  • Dyrks as modifiersof the apc and axin pathways and methods of use
    Publication number: 20060265763
    Abstract: Human DYRK genes are identified as modulators of the APC and Axin pathways, and thus are therapeutic targets for disorders associated with defective APC and Axin function. Methods for identifying modulators of APC and Axin, comprising screening for agents that modulate the activity of DYRK are provided.
    Type: Application
    Filed: February 10, 2004
    Publication date: November 23, 2006
    Applicant: EXELIXIS, INC.
    Inventors: Steven Gendreau, Eva Morablanco, Timothy Hauer, Kim Lickteig
  • Ups as modifiers of the beta catenin pathway and methods of use
    Publication number: 20060246459
    Abstract: Human UP genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of UP are provided.
    Type: Application
    Filed: August 12, 2004
    Publication date: November 2, 2006
    Inventors: Helen Francis-Lang, Christopher Winter, Richard Ventura, Kim Lickteig, Timothy Heuer
  • Facls as modifiers of the rb pathway and methods of use
    Publication number: 20060240433
    Abstract: Human FACL genes are identified as modulators of the RB pathway, and thus are therapeutic targets for disorders associated with defective RB function. Methods for identifying modulators of RB, comprising screening for agents that modulate the activity of FACL are provided.
    Type: Application
    Filed: January 28, 2004
    Publication date: October 26, 2006
    Inventors: Helen Francis-Lang, Kyle Edgar, Kim Lickteig